Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erika M Moore

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
American Journal of Clinical Pathology|March 13, 2021
Clinical Utility of Targeted Next-Generation Sequencing in the Evaluation of Low-Grade Lymphoproliferative DisordersAudrey N Jajosky, Nathaniel P Havens, Navid Sadri, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 9, 2024
Clonal Dynamics and Relapse Risk Revealed by High-Sensitivity FLT3-Internal Tandem Duplication Detection in Acute Myeloid LeukemiaKwadwo Asare Oduro, Theresa Spivey, Erika M Moore, et al.
The American Journal of Surgical Pathology|November 21, 2024
IRF8 Demonstrates Positivity in a Significant Subset of Histiocytic and Dendritic Cell NeoplasmsPranav P Patwardhan, Nathanael G Bailey, Sara A Monaghan, et al.
American Journal of Clinical Pathology|June 17, 2026
Mutation-specific NPM1 immunohistochemistry is a sensitive method for detecting residual disease in mid- and postinduction bone marrows: comparison of NPM1 immunohistochemistry, NPM1 real-time polymerase chain reaction, and flow cytometric studiesEllie Hong, Nathanael G Bailey, Katelynn E Davis, et al.
European Journal of Haematology|January 2, 2021
Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasiaAudrey N Jajosky, Navid Sadri, Howard J Meyerson, et al.
The American Journal of Surgical Pathology|July 22, 2025
The Utility of TRBC1 Immunohistochemistry in the Evaluation of T-Cell LymphomasPranav P Patwardhan, Ahmad Al-Attar, Nidhi Aggarwal, et al.
Journal of Hematopathology|September 12, 2025
Validation of clinicopathologic features of a genetic myelodysplastic syndrome classification in an independent cohortPranav Pramod Patwardhan, Raniah D Al Amri, Vandana Baloda, et al.
Leukemia|July 16, 2024
Validation of independent prognostic significance of blast count in a large cohort of MDS patientsRaniah Al Amri, Vandana Baloda, Sara A Monaghan, et al.
British Journal of Haematology|October 23, 2023
IGJ and SPATS2L immunohistochemistry sensitively and specifically identify BCR::ABL1+ and BCR::ABL1-like B-acute lymphoblastic leukaemiaCatherine K Gestrich, Shanelle J De Lancy, Adam Kresak, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 20, 2025
Myeloid Neoplasms With Oligomonocytosis Exhibit Heterogenous Pathologic and Genetic FeaturesVandana Baloda, Raniah Al Amri, Pranav P Patwardhan, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
American Journal of Clinical Pathology|March 13, 2021
Clinical Utility of Targeted Next-Generation Sequencing in the Evaluation of Low-Grade Lymphoproliferative DisordersAudrey N Jajosky, Nathaniel P Havens, Navid Sadri, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 9, 2024
Clonal Dynamics and Relapse Risk Revealed by High-Sensitivity FLT3-Internal Tandem Duplication Detection in Acute Myeloid LeukemiaKwadwo Asare Oduro, Theresa Spivey, Erika M Moore, et al.
The American Journal of Surgical Pathology|November 21, 2024
IRF8 Demonstrates Positivity in a Significant Subset of Histiocytic and Dendritic Cell NeoplasmsPranav P Patwardhan, Nathanael G Bailey, Sara A Monaghan, et al.
American Journal of Clinical Pathology|June 17, 2026
Mutation-specific NPM1 immunohistochemistry is a sensitive method for detecting residual disease in mid- and postinduction bone marrows: comparison of NPM1 immunohistochemistry, NPM1 real-time polymerase chain reaction, and flow cytometric studiesEllie Hong, Nathanael G Bailey, Katelynn E Davis, et al.
European Journal of Haematology|January 2, 2021
Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasiaAudrey N Jajosky, Navid Sadri, Howard J Meyerson, et al.
The American Journal of Surgical Pathology|July 22, 2025
The Utility of TRBC1 Immunohistochemistry in the Evaluation of T-Cell LymphomasPranav P Patwardhan, Ahmad Al-Attar, Nidhi Aggarwal, et al.
Journal of Hematopathology|September 12, 2025
Validation of clinicopathologic features of a genetic myelodysplastic syndrome classification in an independent cohortPranav Pramod Patwardhan, Raniah D Al Amri, Vandana Baloda, et al.
Leukemia|July 16, 2024
Validation of independent prognostic significance of blast count in a large cohort of MDS patientsRaniah Al Amri, Vandana Baloda, Sara A Monaghan, et al.
British Journal of Haematology|October 23, 2023
IGJ and SPATS2L immunohistochemistry sensitively and specifically identify BCR::ABL1+ and BCR::ABL1-like B-acute lymphoblastic leukaemiaCatherine K Gestrich, Shanelle J De Lancy, Adam Kresak, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 20, 2025
Myeloid Neoplasms With Oligomonocytosis Exhibit Heterogenous Pathologic and Genetic FeaturesVandana Baloda, Raniah Al Amri, Pranav P Patwardhan, et al.
Pageof 4